Spark 200 mg Tablet

Spark 200 mg tablet by Navana Pharmaceuticals Ltd. is a prescription antibiotic medicine that contains Sparfloxacin. In Bangladesh, it may be used when a doctor considers it appropriate for certain susceptible bacterial respiratory tract infections.

Sparfloxacin works by inhibiting bacterial DNA enzymes needed for bacterial growth and replication. A key caution is that it can cause significant photosensitivity and may prolong the QT interval, so it should be used only when clearly prescribed.

• Treatment of community-acquired pneumonia caused by susceptible bacteria.
• Treatment of acute bacterial exacerbation of chronic bronchitis caused by susceptible bacteria.
• It is not effective for viral infections such as colds or influenza.

The adult dose, dosing schedule, and duration must be decided by the prescribing doctor based on the infection, likely organism, kidney function, other medicines, and patient risk factors. It is usually taken by mouth with water, and some regimens use an initial higher dose followed by once-daily dosing. Take exactly as prescribed and complete the course unless a doctor advises stopping.

• Common effects may include nausea, diarrhoea, abdominal discomfort, headache, dizziness, insomnia, and altered taste.
• Photosensitivity reactions, including severe sunburn-like reactions, can occur.
• Serious effects may include tendon inflammation or tendon rupture, peripheral neuropathy, seizures or other central nervous system effects, severe allergic reactions, severe skin reactions, liver injury, and Clostridioides difficile-associated diarrhoea.
• It may prolong the QT interval and rarely cause serious abnormal heart rhythms.
• Changes in blood glucose may occur, especially in people with diabetes.

Use caution in people with heart rhythm problems, known QT prolongation, low potassium or magnesium, significant heart disease, kidney problems, seizure disorders, myasthenia gravis, diabetes, tendon disorders, or a history of serious reaction to quinolone antibiotics. Older adults and people taking corticosteroids have a higher risk of tendon injury. Avoid strong sunlight and tanning lamps during treatment and for several days after stopping. Use Sparfloxacin under the guidance of a registered doctor or pharmacist.

• Antacids, sucralfate, iron, zinc, magnesium, aluminium, calcium supplements, and some multivitamins can reduce absorption; separate administration as advised by a healthcare professional.
• Medicines that prolong the QT interval, including some antiarrhythmics, macrolide antibiotics, antipsychotics, tricyclic antidepressants, and certain other medicines, may increase the risk of serious heart rhythm problems.
• Corticosteroids increase the risk of tendon inflammation and rupture.
• Warfarin and other anticoagulants may have increased effect; monitoring may be needed.
• Antidiabetic medicines or insulin may increase the risk of abnormal blood glucose.
• NSAIDs may increase the risk of central nervous system stimulation or seizures in susceptible patients.

• Known hypersensitivity to sparfloxacin, other quinolone or fluoroquinolone antibiotics, or any component of the product.
• History of tendon disorder related to quinolone use.
• Known QT prolongation, uncorrected low potassium, or use with certain medicines known to significantly prolong the QT interval, unless a specialist specifically determines otherwise.
• Generally avoided in children and adolescents because fluoroquinolones may affect developing cartilage, unless no suitable alternative exists and a specialist prescribes it.

Sparfloxacin is generally avoided during pregnancy and breastfeeding because safer alternatives are usually preferred and fluoroquinolones have potential risks to developing joints/cartilage. It should be used only if a doctor decides the expected benefit outweighs the risk. Breastfeeding mothers should seek medical advice before use.

Store tablets at room temperature in a dry place, protected from light and moisture. Keep out of reach of children and do not use after the expiry date.